Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Johnson and Johnson
AstraZeneca
Mallinckrodt
McKesson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Beximco Pharms Usa Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BEXIMCO PHARMS USA, and what generic and branded alternatives to BEXIMCO PHARMS USA drugs are available?

BEXIMCO PHARMS USA has fourteen approved drugs.



Summary for Beximco Pharms Usa
US Patents:0
Tradenames:13
Ingredients:13
NDAs:14

Drugs and US Patents for Beximco Pharms Usa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Beximco Pharms Usa SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 207429-003 Nov 2, 2018 AB RX No No   Start Trial   Start Trial
Beximco Pharms Usa CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 206676-001 Apr 12, 2019 AA RX No No   Start Trial   Start Trial
Beximco Pharms Usa NADOLOL nadolol TABLET;ORAL 210955-002 Jul 23, 2018 AB RX No No   Start Trial   Start Trial
Beximco Pharms Usa ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075621-001 Aug 22, 2000 DISCN No No   Start Trial   Start Trial
Beximco Pharms Usa SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 207428-002 Oct 21, 2016 AB RX No No   Start Trial   Start Trial
Beximco Pharms Usa RIBAVIRIN ribavirin TABLET;ORAL 202546-004 Aug 12, 2014 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Harvard Business School
Express Scripts
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.